ArticleJMIR cardio2025
Photoplethysmography-Based Machine Learning Approaches for Atrial Fibrillation Burden: Algorithm Development and Validation.
Article in JMIR cardio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07512037 (Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Burden-Evaluated Active Therapy for AF Using Continuous Wearables BEAT-AF Trial
Who cites it
1 citing paper in PubMed.
- Top developments in clinical cardiac electrophysiology-2025.Heart rhythm O2 · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atrial fibrillation (AF) burden is associated with cardiovascular events such as stroke and heart failure. Recent advancements in photoplethysmography (PPG) technology have provided new insights into noninvasive and convenient AF burden detection. Objective: This study aimed to establish an AF burden model based on smartwatch-monitored PPG technology to track the progression of AF. Methods: This prospective pilot study (January 2024 to January 2025) at the Chinese PLA General Hospital enrolled patients with paroxysmal AF. Participants underwent simultaneous rhythm monitoring using smartwatch PPG and 24-hour Holter electrocardiogram monitoring (the gold standard). Five PPG-derived AF burden metrics were defined: (1) ratio of AF episode duration to total monitoring time (M1), (2) ratio of AF episode frequency to total measurements (M2), (3) AF episode density (M3), (4) AF episode variability (M4), and (5) proportion of rapid ventricular rate in AF episodes (>120 beats per minute; M5). Smartwatch PPG signals were collected once per minute. Sensitivity, specificity, accuracy, precision, and F1 score were used to evaluate the PPG algorithm's AF detection capability through comparison with the gold standard (24-hour Holter monitoring). The mean absolute error (MAE) and Spearman rank correlation coefficient (rs) were used to assess the correlation between the PPG-based AF burden metrics and the gold standard. Results: A total of 145 participants with paroxysmal AF (n=96, 66.2% male; mean age 63.28, SD 14.23 years) were included. Compared to the gold standard, the PPG-based AF burden model demonstrated a sensitivity of 91.5% (95% CI 87.9%-95.1%), specificity of 97.2% (95% CI 95.9%-98.5%), precision of 92.9% (95% CI 88.6%-97.3%), accuracy of 93.3% (95% CI 88.2%-98.5%), and F1 score of 90.5% (95% CI 86.3%-94.7%). The AF burden model exhibited strong discriminatory power in the test cohort (area under the curve=89.5%, 95% CI 89.4%-89.7%). For M1, the MAE for the model of AF episode duration as a proportion of total monitoring time was 0.0400 (P=.008), with a correlation coefficient (rs) of 0.8788 (P<.001). For M4, the MAE for the AF episode variability model was 3.9967 (P<.001), with a correlation coefficient (rs) of 0.7876 (P<.001). The MAE for the average real variability model was 4.6436 (P<.001), with a correlation coefficient (rs) of 0.8127 (P<.001). The MAE for the average AF change model was 0.3893 (P=.27), with a correlation coefficient (rs) of 0.7246 (P<.001). Conclusions: The PPG-based AF burden model demonstrated high concordance with the gold standard of 24-hour Holter monitoring in tracking AF episode duration and variability, providing new perspectives for exploring AF progression dynamics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.